Brad Canino Score: 45
Analyst at
Guggenheim
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+52.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
59%
10 W / 7 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
80%
4 W / 1 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
20%
1 W / 4 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
20%
1 W / 4 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
56%
9 W / 7 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
59%
10 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$170.00
Est. +44%
|
$118.15 | $123.43 |
Pending
|
$117.39
-0.6%
|
| Aug 17, 2026 |
Celcuity Inc
CELC
|
BUY |
$175.00
Est. +90%
|
$92.00 | $97.82 |
Pending
|
$95.70
+4.0%
|
| Jul 24, 2026 |
Summit Therapeutics Inc
SMMT
|
BUY |
$38.00
Est. +154%
|
$14.98 | $17.63 |
Pending
|
$17.61
+17.5%
|
| Jun 12, 2026 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$31.00
Est. +73%
|
$17.91 | $25.24 |
Pending
|
$20.56
+14.8%
|
| Jun 10, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$124.00
Est. +1%
|
$123.25 | $123.99 |
Bullseye Hit (±1%)
|
$123.96
+0.6%
|
| May 26, 2026 |
Relay Therapeutics Inc
RLAY
|
BUY |
$26.00
Est. +92%
|
$13.53 | $20.98 |
Pending
|
$19.04
+40.7%
|
| May 04, 2026 |
Celcuity Inc
CELC
|
BUY |
$165.00
Est. +31%
|
$125.65 | $151.02 |
Pending
|
$95.70
-23.8%
|
| Apr 14, 2026 |
Tyra Biosciences Inc
TYRA
|
BUY |
$54.00
Est. +53%
|
$35.27 | $38.63 |
Pending
|
$28.65
-18.8%
|
| Mar 13, 2026 |
Relay Therapeutics Inc
RLAY
|
BUY |
$22.00
Est. +104%
|
$10.81 | $20.98 |
Pending
|
$19.04
+76.1%
|
| Jan 21, 2026 |
Catalyst Biosciences Inc
CBIO
|
BUY |
$35.00
Est. +150%
|
$13.98 | $27.41 |
Pending
|
$20.88
+49.4%
|
| Nov 03, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$90.00
Est. +46%
|
$61.84 | $130.05 |
Target Met
|
$117.39
+89.8%
|
| Oct 07, 2025 |
Cg Oncology Inc.
CGON
|
BUY |
$90.00
Est. +137%
|
$38.00 | $80.07 |
Pending
|
$74.67
+96.5%
|
| Sep 04, 2025 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$18.00
Est. +70%
|
$10.60 | $14.93 |
Miss
|
$12.86
+21.3%
|
| Sep 03, 2025 |
Janux Therapeutics Inc
JANX
|
BUY |
$72.00
Est. +213%
|
$23.04 | $35.25 |
Miss
|
$20.24
-12.2%
|
| Sep 03, 2025 |
Black Diamond Therapeutics Inc
BDTX
|
BUY |
$8.00
Est. +178%
|
$2.88 | $4.94 |
Miss
|
$2.12
-26.4%
|
Kymera Therapeutics Inc
KYMR
Aug 31, 2026
Signal & Target
BUY
$170.00
Start Price
$118.15
Best Price (1Y)
$123.43
Current Price
$117.39
Return
-0.6%
Celcuity Inc
CELC
Aug 17, 2026
Signal & Target
BUY
$175.00
Start Price
$92.00
Best Price (1Y)
$97.82
Current Price
$95.70
Return
+4.0%
Summit Therapeutics Inc
SMMT
Jul 24, 2026
Signal & Target
BUY
$38.00
Start Price
$14.98
Best Price (1Y)
$17.63
Current Price
$17.61
Return
+17.5%
Syndax Pharmaceuticals Inc
SNDX
Jun 12, 2026
Signal & Target
BUY
$31.00
Start Price
$17.91
Best Price (1Y)
$25.24
Current Price
$20.56
Return
+14.8%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Jun 10, 2026
Signal & Target
BUY
$124.00
Start Price
$123.25
Best Price (1Y)
$123.99
Current Price
$123.96
Return
+0.6%
Relay Therapeutics Inc
RLAY
May 26, 2026
Signal & Target
BUY
$26.00
Start Price
$13.53
Best Price (1Y)
$20.98
Current Price
$19.04
Return
+40.7%
Celcuity Inc
CELC
May 04, 2026
Signal & Target
BUY
$165.00
Start Price
$125.65
Best Price (1Y)
$151.02
Current Price
$95.70
Return
-23.8%
Tyra Biosciences Inc
TYRA
Apr 14, 2026
Signal & Target
BUY
$54.00
Start Price
$35.27
Best Price (1Y)
$38.63
Current Price
$28.65
Return
-18.8%
Relay Therapeutics Inc
RLAY
Mar 13, 2026
Signal & Target
BUY
$22.00
Start Price
$10.81
Best Price (1Y)
$20.98
Current Price
$19.04
Return
+76.1%
Catalyst Biosciences Inc
CBIO
Jan 21, 2026
Signal & Target
BUY
$35.00
Start Price
$13.98
Best Price (1Y)
$27.41
Current Price
$20.88
Return
+49.4%
Kymera Therapeutics Inc
KYMR
Nov 03, 2025
Signal & Target
BUY
$90.00
Start Price
$61.84
Best Price (1Y)
$130.05
Current Price
$117.39
Return
+89.8%
Cg Oncology Inc.
CGON
Oct 07, 2025
Signal & Target
BUY
$90.00
Start Price
$38.00
Best Price (1Y)
$80.07
Current Price
$74.67
Return
+96.5%
ORIC Pharmaceuticals Inc
ORIC
Sep 04, 2025
Signal & Target
BUY
$18.00
Start Price
$10.60
Best Price (1Y)
$14.93
Current Price
$12.86
Return
+21.3%
Janux Therapeutics Inc
JANX
Sep 03, 2025
Signal & Target
BUY
$72.00
Start Price
$23.04
Best Price (1Y)
$35.25
Current Price
$20.24
Return
-12.2%
Black Diamond Therapeutics Inc
BDTX
Sep 03, 2025
Signal & Target
BUY
$8.00
Start Price
$2.88
Best Price (1Y)
$4.94
Current Price
$2.12
Return
-26.4%